Dominating First Page Rankings On Google

Dominating First Page Rankings On Google written by John Jantsch read more at Duct Tape Marketing

Marketing Podcast with Chris Dreyer

In this episode of the Duct Tape Marketing Podcast, I interview Chris Dreyer. Chris is the CEO of Rankings.io which is an SEO agency that helps elite personal injury law firms dominate first page rankings. 

Key Takeaway:

Search engine optimization is a tough industry especially for a lot of small business owners. And how do you keep up with Google’s constantly changing algorithm? There’s no magic, but there are steps you can take to soar to the top of a search engine results page. In this episode, Chris Dreyer and I dive deep into his experience running an SEO agency and how he’s managed to help small businesses within his industry dominate first page rankings on Google.

Questions I Ask Chris Dreyer:

  • [0:55] What led you to where you are today, and what does your online and entrepreneurial journey look like?
  • [4:05] How do you build trust around SEO when there’s a real lack of trust in the industry?
  • [5:37] As an SEO firm, how important is your own SEO?
  • [6:50] What are the basics of good SEO for any business?
  • [8:02] When you mention landing pages, are you really talking about the importance of the entire structure of the landing pages as well?
  • [9:49] What would you do, if anything, differently because of the competitive nature of this business?
  • [18:48] Core web vitals are being talked about a lot this year — how are you responding or reacting to that?
  • [20:49] When it comes to your ads and organic mix, what’s your philosophy on the mixture of the two — notwithstanding the results they can produce, but sort of the necessary element of them?
  • [23:54] What’s your philosophy on reporting and communication with clients?

More About Chris Dreyer:

More About The Certified Marketing Manager Program Powered by Duct Tape Marketing

Like this show? Click on over and give us a review on iTunes, please!

This episode of the Duct Tape Marketing Podcast is brought to you by .Online.

.Online is one of the world’s most popular new domain extensions with over a million domain names already registered on it. With more and more businesses going online, finding great domain names can be a challenge. .Online allows you to get a brandable and meaningful domain name, and it’s as simple as www.[your brand name].online.

 

 

Chewy shares leap 13% after surprise swing to quarterly profit

Chewy Taco Cat Halloween Costume
  • Chewy shares climbed by 13% Wednesday following the fourth-quarter results from the pet-products seller.
  • The company swung to a profit of $0.05 a share, surprising analysts who had expected a loss of $0.10 a share.
  • Chewy’s first-quarter sales forecast of $2.11 billion to $2.13 billion was above Wall Street’s target.
  • See more stories on Insider’s business page.

Shares of Chewy jumped Wednesday after the online pet-products retailer unexpectedly swung to a fourth-quarter profit, bolstered by millions of more people last year who took on duties of caring for animals during the COVID-19 pandemic.

The company late Tuesday posted fourth-quarter earnings of $0.05 a share, compared with expectations for a loss of $0.10 a share in a survey of analysts by Refinitiv. A year earlier, Chewy posted a per-share loss of $0.15.

Sales of $2.04 billion beat Wall Street’s target of $1.96 billion as the company dealt with “surging volume”. Sales a year ago were $1.35 billion.

Chewy shares climbed by 13% to $90.95, a move that sets up the stock to trim its year-to-date loss to less than 1%. The stock price began to decelerate in early February but it’s more than doubled from about $36 over the past 12 months.

The company added 5.7 million net active customers in 2020, representing 42.7% annual growth. It also said it widened its product offerings to include gift cards, personalized items, and vet services. “Pet adoptions surged in 2020 as millions of homebound people and families sought out the comfort, companionship, and joy of pet parenthood” during the pandemic, the company said.

Chewy forecast first-quarter sales of $2.11 billion to $2.13 billion, higher than the average analyst forecast of $2.07 billion.

Wedbush analysts on Wednesday raised their price target to $100 from $90 and reiterated their outperform rating on Chewy following the company’s “solid earnings beat, above-consensus guidance, and a path to a 2021 beat and even higher long-term earnings power.”

Chewy’s cofounder and former chief executive, Ryan Cohen, is leading a turnaround effort at video game retailer and Reddit-community favorite GameStop.

Read the original article on Business Insider

Twitter CEO Jack Dorsey was caught red-handed trolling Congress by tweeting a sarcastic poll during a Big Tech hearing

Jack Dorsey
Twitter CEO Jack Dorsey.

  • Jack Dorsey was called out for tweeting during a congressional hearing about misinformation online.
  • The Twitter CEO tweeted a poll that appeared to mock the simple “yes or no” answers lawmakers demanded.
  • Rep. Kathleen Rice told Dorsey that his “multi-tasking skills are quite impressive.”
  • See more stories on Insider’s business page.

Twitter boss Jack Dorsey on Thursday was busted tweeting a saracastic poll during a congressional hearing about misinformation on social media platforms.

Lawmakers grilled Dorsey, as well as Google CEO Sundar Pichai and Facebook CEO Mark Zuckerberg, about their sites’ handling of vaccine misinformation, election fraud claims, and online extremism.

Congress asked the three CEOs to answer “yes or no” to a range of complicated, extensive questions. Lawmakers sometimes interrupted if the CEOs tried to give longer answers.

During the hearing, Dorsey took a jab at the tactic by tweeting a poll that was simply a question mark, asking Twitter users to vote “yes” or “no.”

Read more: Here are some of the potential future CEOs in big tech, and how much they’re currently paid

Democratic Rep. Kathleen Rice picked up on Dorsey’s tweet and asked him: “Mr Dorsey, what is winning, yes or no, on your Twitter account poll?”

Dorsey said that “yes” was in the lead. Rice replied: “Hmm, your multitasking skills are quite impressive.”

At the time of publication, the poll has more than 97,000 votes.

While facing Congress, the 44-year-old was also liking tweets that pointed out lawmakers were mispronouncing Pichai’s name, as well as cutting off the CEOs mid-sentence.

Dorsey, who founded Twitter in 2006, confirmed to another Twitter user that he was barefoot in the hearing.

Dorsey also retweeted a Twitter user’s post that said: “It would be awesome if some Member engaged [Jack] in a substantive discussion on Twitter’s ‘protocols’ idea.” Dorsey tweeted about Twitter’s protocols idea before the hearing. He said the company had started working on a decentralized, open-source social media protocol called Bluesky, which could allow users to build their own media platform that is solely owned by them.

Social-media platforms have faced heavy scrutiny over the past year for the way they have policed misinformation during the pandemic, particularly during the presidential election and the Capitol riots. The five-hour long hearing on Thursday was the first time the tech CEOs had faced Congress since President Joe Biden’s inauguration.

Twitter said March 1 that it would ban users who repeatedly post misinformation about COVID-19 vaccines on the platform. It also said tweets that contain misleading information would be labeled.

One month before the election, the company said it changed some features to prevent the spread of false political claims, including prompting users to post a comment about a tweet before retweeting it.

Lawmakers in Thursday’s hearing said the changes to the platform didn’t go far enough. They could still easily find anti-vaccine content on both Twitter and Facebook, Rep. Mike Doyle, chair of the House subcommittee on Communications and Technology, said, per CNN.

Read the original article on Business Insider

Amazon is reportedly eyeing a $100 million investment in the Apollo Pharmacy chain, further expanding its healthcare plans

Amazon Pharmacy
Amazon considers $100 million investment in India’s pharmacy chain

  • Amazon is looking to invest nearly $100 million in Apollo Pharmacy, the Indian pharmacy chain, two people familiar with the plans told the Economic Times Wednesday.
  • Amazon’s plans to expand in India come after the launch of its own Amazon Pharmacy service in the US November 17, allowing people to buy prescription drugs through its website.
  • The potential investment would come amid competition in India from Mukesh Ambani’s Reliance, which recently bought a majority stake in online pharmacy Netmeds.
  • Indian trader groups say online drugstores can contribute to medicine sales without proper verification.
  • Visit Business Insider’s homepage for more stories.

Amazon is reportedly considering a nearly $100 million investment in India’s pharmacy chain Apollo Pharmacy, close on the heels of its launch of an online pharmacy to deliver prescription drugs in the US.

The company is looking to face up to Reliance Industries Ltd and Tata Group in India’s fast-growing drug market, the Economic Times reported Wednesday, citing two people aware of the plans. 

Amazon already delivers medicines in India and the potential investment would come amid rising competition from Mukesh Ambani’s Reliance, which bought a majority stake in online pharmacy Netmeds.

Both Amazon and Apollo Hospitals, which owns Apollo Pharmacy, declined to comment to Reuters.

The growth of e-pharmacies has left many Indian trader groups feeling threatened. They say online drugstores can contribute to medicine sales without proper verification and the entry of large players can cause unemployment in the sector.

Amazon’s plan to further expand in India comes after it launched its US Amazon Pharmacy service November 17, increasing its competition with drug retailers such as Walgreens, CVS Health and Walmart.

US customers can now buy drugs through Amazon’s main website.

Amazon Prime members would get benefits from the service including two-day delivery and big price cuts on generic and brand-name drugs, the company said.

Read more: Read the leaked talking points that Amazon Web Services employees are using to explain its recent massive cloud outage: ‘There is no compression algorithm for experience’

Since 2018, when the company bought a small drug-delivery startup called PillPack, industry watchers have been expecting Amazon to move into delivering drugs.

In June 2019, Amazon launched a brand of over-the-counter medication, and in August 2020, the company launched a health-monitoring wristband called Halo.

Business Insider reported in November that as the retail firm expands into healthcare, it would need to be careful not to scare consumers who may be concerned about their data privacy.

Read the original article on Business Insider